| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.446 | 3.384 | 12.199 | 8.396 | 13.721 | 23.378 | 11.179 | 7.902 | 5.202 | 1.056 |
| Total Income - EUR | 13.585 | 9.121 | 16.629 | 50.543 | 14.814 | 24.166 | 15.303 | 11.314 | 5.282 | 1.516 |
| Total Expenses - EUR | 14.623 | 18.097 | 19.383 | 16.135 | 17.076 | 24.971 | 14.504 | 16.796 | 16.196 | 19.264 |
| Gross Profit/Loss - EUR | -1.038 | -8.976 | -2.754 | 34.408 | -2.262 | -805 | 799 | -5.482 | -10.914 | -17.747 |
| Net Profit/Loss - EUR | -1.292 | -9.044 | -2.876 | 33.904 | -2.411 | -1.019 | 649 | -5.569 | -10.966 | -17.747 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - A-Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 485 | 444 | 419 | 375 | 333 | 292 | 252 | 219 | 199 | 126 |
| Current Assets | 65.594 | 60.786 | 70.352 | 49.867 | 49.493 | 51.074 | 54.366 | 36.939 | 1.656 | 2.018 |
| Inventories | 4.966 | 4.879 | 20.495 | 17.935 | 14.238 | 8.482 | 6.018 | 4.518 | 459 | 349 |
| Receivables | 2.022 | 2.226 | 13.180 | 6.082 | 4.636 | 3.088 | 3.024 | 1.958 | 1.133 | 1.625 |
| Cash | 58.607 | 53.681 | 36.677 | 25.850 | 30.619 | 39.504 | 45.324 | 30.463 | 65 | 43 |
| Shareholders Funds | -6.971 | -15.943 | -18.550 | 15.694 | 12.979 | 11.714 | 12.104 | 6.572 | -5.183 | -22.901 |
| Social Capital | 682 | 675 | 663 | 651 | 639 | 626 | 613 | 614 | 613 | 609 |
| Debts | 73.234 | 77.327 | 89.386 | 34.586 | 36.886 | 39.688 | 42.515 | 30.586 | 7.038 | 24.563 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 482 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4673 - 4673" | |||||||||
| CAEN Financial Year |
4673
|
|||||||||
Comments - A-Med S.r.l.